News
Catalyst Pharmaceuticals stock shines with FIRDAPSE & AGAMREE growth. Learn why the biopharma name is cheap enough to start ...
Duchenne (SGT-003): 15 participants dosed in the Phase 1/2 INSPIRE DUCHENNE trial and dosing remains ongoing; On track to ...
A Food and Drug Administration official is getting his job back as the agency’s top vaccine regulator, less than two weeks ...
BACK TO CBER — Dr. Vinay Prasad has returned to the FDA’s Center for Biologics Evaluation and Research, leaving industry and ...
Sarepta’s troubles had nothing to do with Arrowhead’s assets, and yet both companies have seen their stock prices decline ...
Vinay Prasad resumes leadership at the FDA’s CBER two weeks after he resigned amid cell and gene therapy controversy.
22h
TipRanks on MSNQuince Therapeutics Reports Q2 2025 Financial Results
Quince Therapeutics ( ($QNCX) ) has released its Q2 earnings. Here is a breakdown of the information Quince Therapeutics presented to its ...
22h
MedPage Today on MSNCats Show Alzheimer's Changes; MS Lesions Start Early; Contested Paper Retracted
Amyloid-beta exerted a pathogenic effect in cats with dementia, suggesting feline cognitive dysfunction syndrome may be a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results